Amr Abdin

986 total citations
39 papers, 434 citations indexed

About

Amr Abdin is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Surgery. According to data from OpenAlex, Amr Abdin has authored 39 papers receiving a total of 434 indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Cardiology and Cardiovascular Medicine, 9 papers in Endocrinology, Diabetes and Metabolism and 6 papers in Surgery. Recurrent topics in Amr Abdin's work include Heart Failure Treatment and Management (26 papers), Cardiovascular Function and Risk Factors (13 papers) and Cardiac pacing and defibrillation studies (12 papers). Amr Abdin is often cited by papers focused on Heart Failure Treatment and Management (26 papers), Cardiovascular Function and Risk Factors (13 papers) and Cardiac pacing and defibrillation studies (12 papers). Amr Abdin collaborates with scholars based in Germany, United Kingdom and United States. Amr Abdin's co-authors include Michael Böhm, Stefan D. Anker, Giuseppe Rosano, Jan Wintrich, Davor Vukadinović, Ingrid Kindermann, P. DeBuse, Abdülbari Bener, Yousef M. Abdulrazzaq and Mitja Lainščak and has published in prestigious journals such as Journal of the American College of Cardiology, European Heart Journal and European Journal of Heart Failure.

In The Last Decade

Amr Abdin

32 papers receiving 420 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Amr Abdin Germany 14 330 78 72 51 24 39 434
Åsa Jonsson Sweden 11 360 1.1× 59 0.8× 145 2.0× 31 0.6× 10 0.4× 14 495
Teresa Mota Portugal 6 426 1.3× 32 0.4× 59 0.8× 65 1.3× 36 1.5× 18 524
José Manuel García Pinilla Spain 9 289 0.9× 61 0.8× 75 1.0× 72 1.4× 15 0.6× 30 379
Efraín Gaxiola United States 12 330 1.0× 93 1.2× 59 0.8× 167 3.3× 12 0.5× 22 490
Fernando Matias Portugal 7 427 1.3× 32 0.4× 64 0.9× 75 1.5× 32 1.3× 14 527
Mustafa Ridha Kuwait 13 346 1.0× 54 0.7× 78 1.1× 78 1.5× 13 0.5× 39 450
Wacław Kochman Poland 11 312 0.9× 65 0.8× 42 0.6× 161 3.2× 16 0.7× 39 435
Patric Karlström Sweden 10 516 1.6× 23 0.3× 78 1.1× 93 1.8× 13 0.5× 23 608
Romeu Sérgio Meneghelo Brazil 10 200 0.6× 36 0.5× 64 0.9× 46 0.9× 35 1.5× 37 369
Hanne Maare Søndergaard Denmark 12 221 0.7× 95 1.2× 49 0.7× 83 1.6× 11 0.5× 33 404

Countries citing papers authored by Amr Abdin

Since Specialization
Citations

This map shows the geographic impact of Amr Abdin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amr Abdin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amr Abdin more than expected).

Fields of papers citing papers by Amr Abdin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amr Abdin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amr Abdin. The network helps show where Amr Abdin may publish in the future.

Co-authorship network of co-authors of Amr Abdin

This figure shows the co-authorship network connecting the top 25 collaborators of Amr Abdin. A scholar is included among the top collaborators of Amr Abdin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amr Abdin. Amr Abdin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Abdin, Amr, Saarraaken Kulenthiran, Michel Komajda, et al.. (2025). Ivabradine Improves Win Ratios of Heart Failure Outcomes in Patients with Reduced Ejection Fraction – Insights from the SHIFT Trial. European Journal of Heart Failure. 27(8). 1479–1481. 1 indexed citations
2.
Abdin, Amr, Wissam Al-Jundi, Bernhard Haring, et al.. (2024). Cardio-Ocular Syndrome: Retinal Microvascular Changes in Acutely Decompensated Heart Failure. European Journal of Heart Failure. 26(11). 2421–2430. 4 indexed citations
3.
Abdin, Amr, Stefan D. Anker, Martín Cowie, et al.. (2023). Associations between baseline heart rate and blood pressure and time to events in HFrEF patients: data from the QUALIFY international registry. European Heart Journal. 44(Supplement_2).
4.
Vukadinović, Davor, Amr Abdin, Insa E. Emrich, et al.. (2023). Efficacy and safety of intravenous iron repletion in patients with heart failure: a systematic review and meta-analysis. Clinical Research in Cardiology. 112(7). 954–966. 14 indexed citations
5.
Böhm, Michael, Amr Abdin, Felix Mahfoud, et al.. (2023). Time to Benefit of Heart Rate Reduction with Ivabradine in Patients with Heart Failure and Reduced Ejection Fraction. European Journal of Heart Failure. 25(8). 1429–1435. 5 indexed citations
6.
Abdin, Amr, Michel Komajda, Jeffrey Borer, et al.. (2023). Efficacy of Ivabradine in Heart Failure Patients with a High-Risk Profile (Analysis from the SHIFT Trial). ESC Heart Failure. 10(5). 2895–2902. 3 indexed citations
7.
8.
Wintrich, Jan, Amr Abdin, & Michael Böhm. (2022). Management strategies in heart failure with preserved ejection fraction. Herz. 47(4). 332–339. 3 indexed citations
9.
Böhm, Michael, Javed Butler, Gerasimos Filippatos, et al.. (2022). Empagliflozin Improves Outcomes in Patients With Heart Failure and Preserved Ejection Fraction Irrespective of Age. Journal of the American College of Cardiology. 80(1). 1–18. 39 indexed citations
10.
11.
Vukadinović, Davor, Amr Abdin, Stefan D. Anker, et al.. (2022). Side effects and treatment initiation barriers of sodium–glucose cotransporter 2 inhibitors in heart failure: a systematic review and meta‐analysis. European Journal of Heart Failure. 24(9). 1625–1632. 19 indexed citations
12.
Abdin, Amr, Martin Schulz, Rolf Wachter, et al.. (2022). Sacubitril/Valsartan in Heart Failure: Efficacy and Safety in and Outside Clinical Trials. ESC Heart Failure. 9(6). 3737–3750. 23 indexed citations
13.
Abdin, Amr, et al.. (2022). Application of Recommended Therapies Among Patients with Heart Failure During the Syrian Conflict: Reality and Barriers. ESC Heart Failure. 9(6). 4003–4009. 2 indexed citations
14.
Abdin, Amr, et al.. (2022). A Practical Approach to the Guideline-Directed Pharmacological Treatment of Heart Failure with Reduced Ejection Fraction. ESC Heart Failure. 10(1). 24–31. 19 indexed citations
15.
Abdin, Amr & Suleman Aktaa. (2022). Subcutaneous ICD for more and transvenous ICD for few?!. Clinical Research in Cardiology. 111(5). 475–478. 1 indexed citations
16.
Rosano, Giuseppe, Larry A. Allen, Amr Abdin, et al.. (2021). Drug Layering in Heart Failure. JACC Heart Failure. 9(11). 775–783. 33 indexed citations
17.
Abdin, Amr, Stefan D. Anker, Javed Butler, et al.. (2021). ‘Time is Prognosis’ in Heart Failure: Time-to-Treatment Initiation as a Modifiable Risk Factor. ESC Heart Failure. 8(6). 4444–4453. 71 indexed citations
18.
Böhm, Michael, Birgit Aßmus, Stefan D. Anker, et al.. (2021). Less Loop Diuretic Use in Patients on Sacubitril/Valsartan Undergoing Remote Pulmonary Artery Pressure Monitoring. ESC Heart Failure. 9(1). 155–163. 8 indexed citations
19.
Jobs, Alexander, Amr Abdin, Suzanne de Waha‐Thiele, et al.. (2019). Angiotensin-converting-enzyme inhibitors in hemodynamic congestion: a meta-analysis of early studies. Clinical Research in Cardiology. 108(11). 1240–1248. 13 indexed citations
20.
Abdin, Amr, Kıvanç Yalın, Matthias Daniel Zink, et al.. (2019). Incidence and predictors of pacemaker induced cardiomyopathy: A single-center experience. Journal of Electrocardiology. 57. 31–34. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Åsa Jonsson Breakdown of academic impact, for papers by Teresa Mota Breakdown of academic impact, for papers by José Manuel García Pinilla Breakdown of academic impact, for papers by Efraín Gaxiola Breakdown of academic impact, for papers by Fernando Matias Breakdown of academic impact, for papers by Mustafa Ridha Breakdown of academic impact, for papers by Wacław Kochman Breakdown of academic impact, for papers by Patric Karlström Breakdown of academic impact, for papers by Romeu Sérgio Meneghelo Breakdown of academic impact, for papers by Hanne Maare Søndergaard
Rankless by CCL
2026